New treatment approach may benefit relapsed post-transplant blood cancer patients – News-Medical.net

For many patients with advanced blood cancers, a stem-cell transplant can drive the disease into remission. However, about one-third of these patients experience a relapse and face a very poor prognosis. But a Dana-Farber Cancer Institute study published in the New England Journal of Medicine suggests that a new treatment approach, using repeated doses of … Continue reading “New treatment approach may benefit relapsed post-transplant blood cancer patients – News-Medical.net”